TY - JOUR
T1 - Comparative Outcomes of Unilateral vs Bilateral Revascularization in Moyamoya Disease
T2 - A Multicenter Retrospective Study
AU - Musmar, Basel
AU - Roy, Joanna M.
AU - Abdalrazeq, Hammam
AU - Kaul, Anand
AU - Atallah, Elias
AU - El Naamani, Kareem
AU - Chen, Ching Jen
AU - Jabre, Roland
AU - Saad, Hassan
AU - Grossberg, Jonathan A.
AU - Dmytriw, Adam A.
AU - Patel, Aman B.
AU - Khorasanizadeh, Mirhojjat
AU - Ogilvy, Christopher S.
AU - Thomas, Ajith J.
AU - Monteiro, Andre
AU - Siddiqui, Adnan
AU - Cortez, Gustavo M.
AU - Hanel, Ricardo A.
AU - Porto, Guilherme
AU - Spiotta, Alejandro M.
AU - Piscopo, Anthony J.
AU - Hasan, David M.
AU - Ghorbani, Mohammad
AU - Weinberg, Joshua
AU - Nimjee, Shahid M.
AU - Bekelis, Kimon
AU - Salem, Mohamed M.
AU - Burkhardt, Jan Karl
AU - Zetchi, Akli
AU - Matouk, Charles
AU - Howard, Brian M.
AU - Lai, Rosalind
AU - Du, Rose
AU - Abbas, Rawad
AU - Sioutas, Georgios S.
AU - Amllay, Abdelaziz
AU - Munoz, Alfredo
AU - Herial, Nabeel A.
AU - Tjoumakaris, Stavropoula I.
AU - Gooch, Michael Reid
AU - Rosenwasser, Robert H.
AU - Jabbour, Pascal
N1 - Publisher Copyright:
© Congress of Neurological Surgeons 2024. Unauthorized reproduction of this article is prohibited.
PY - 2025/6
Y1 - 2025/6
N2 - BACKGROUND AND OBJECTIVES:Moyamoya disease (MMD) is characterized by progressive steno-occlusion of the internal carotid arteries, leading to compensatory collateral vessel formation. The optimal surgical approach for MMD remains debated, with bilateral revascularization potentially offering more comprehensive protection but involving more extensive surgery compared to unilateral revascularization. This study aims to compare bilateral revascularization and unilateral revascularization short-term safety profile in the treatment of MMD.METHODS:This multicenter retrospective study included patients with MMD who underwent surgical revascularization at 13 academic institutions. Patients were categorized into unilateral and bilateral revascularization groups. Data collected included demographics, clinical characteristics, and outcomes. Propensity score matching was used to balance baseline characteristics. Statistical analyses were conducted using Stata (V.17.0; StataCorp).RESULTS:A total of 497 patients were included, including 90 who had bilateral revascularization and 407 who had unilateral revascularization. Bilateral revascularization was associated with more perioperative asymptomatic strokes (10% vs 2.4%; odds ratio [OR] 4.41, 95% CI 1.73 to 11.19, P =.002) and higher rates of excellent functional outcomes (modified Rankin Scale 0-1) at discharge (92.2% vs 79.1%; OR 3.12, 95% CI 1.39 to 7, P =.006). After propensity score matching, 57 matched pairs were analyzed. There was a higher rate, though not statistically significant difference, of perioperative stroke in the bilateral revascularization group (15.7% vs 8.7%; OR 1.95, 95% CI 0.61 to 6.22, P =.26). No significant differences were noted in modified Rankin scale 0 to 1 and 0 to 2 scores at discharge, National Institute of Health Stroke Scale at discharge, intraoperative complications, or length of hospital stay. The follow-up stroke rates were also not significantly different (OR 0.40, 95% CI 0.11 to 1.39, P =.15).CONCLUSION:This study found no significant differences between bilateral and unilateral revascularization in MMD. Patients who had bilateral revascularization had higher tendency of perioperative stroke, though not statistically significant. Further prospective studies are needed to validate these results.
AB - BACKGROUND AND OBJECTIVES:Moyamoya disease (MMD) is characterized by progressive steno-occlusion of the internal carotid arteries, leading to compensatory collateral vessel formation. The optimal surgical approach for MMD remains debated, with bilateral revascularization potentially offering more comprehensive protection but involving more extensive surgery compared to unilateral revascularization. This study aims to compare bilateral revascularization and unilateral revascularization short-term safety profile in the treatment of MMD.METHODS:This multicenter retrospective study included patients with MMD who underwent surgical revascularization at 13 academic institutions. Patients were categorized into unilateral and bilateral revascularization groups. Data collected included demographics, clinical characteristics, and outcomes. Propensity score matching was used to balance baseline characteristics. Statistical analyses were conducted using Stata (V.17.0; StataCorp).RESULTS:A total of 497 patients were included, including 90 who had bilateral revascularization and 407 who had unilateral revascularization. Bilateral revascularization was associated with more perioperative asymptomatic strokes (10% vs 2.4%; odds ratio [OR] 4.41, 95% CI 1.73 to 11.19, P =.002) and higher rates of excellent functional outcomes (modified Rankin Scale 0-1) at discharge (92.2% vs 79.1%; OR 3.12, 95% CI 1.39 to 7, P =.006). After propensity score matching, 57 matched pairs were analyzed. There was a higher rate, though not statistically significant difference, of perioperative stroke in the bilateral revascularization group (15.7% vs 8.7%; OR 1.95, 95% CI 0.61 to 6.22, P =.26). No significant differences were noted in modified Rankin scale 0 to 1 and 0 to 2 scores at discharge, National Institute of Health Stroke Scale at discharge, intraoperative complications, or length of hospital stay. The follow-up stroke rates were also not significantly different (OR 0.40, 95% CI 0.11 to 1.39, P =.15).CONCLUSION:This study found no significant differences between bilateral and unilateral revascularization in MMD. Patients who had bilateral revascularization had higher tendency of perioperative stroke, though not statistically significant. Further prospective studies are needed to validate these results.
KW - MMD
KW - Moyamoya disease
KW - Multicenter
KW - Revascularization
UR - https://www.scopus.com/pages/publications/105005536486
U2 - 10.1227/neu.0000000000003243
DO - 10.1227/neu.0000000000003243
M3 - Article
C2 - 39465938
AN - SCOPUS:105005536486
SN - 0148-396X
VL - 96
SP - 1364
EP - 1373
JO - Neurosurgery
JF - Neurosurgery
IS - 6
ER -